About This Report
This new 280-page report from Venture Planning Group presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes I/II, VI, Papillomavirus Pap Smear, HPV, and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 280 pages and 15 tables.
SIMILAR MARKET STUDIES
2015-2019 Global Rubella Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-US, Europe (France, Germany, Italy, Spain, UK) , Japan
The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ...
September 2015 | $2800 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product ...
October 2013 | $3950 | View Details >>
2017 U.K. Nucleic Acid Testing/NAT Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Opportunities-Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
March 2017 | $0 | View Details >>
This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including:
January 2014 | $3500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research